MindWalk Holdings (HYFT) Interest Expenses (2020 - 2026)
MindWalk Holdings' (HYFT) quarterly Interest Expenses came in at -$3647.5 in Q2 2026, down 29.76% year-over-year from -$5193.2 in Q2 2025, and down 29.76% quarter-over-quarter from -$2810.9 in Q2 2025.
Analysis
MindWalk Holdings (HYFT) Interest Expenses (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Interest Expenses for 7 consecutive years, with -$3647.5 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Interest Expenses fell 29.76% year-over-year to -$3647.5 in Q2 2026; TTM through Apr 2026 was -$6458.4, a 35.87% increase from a year earlier, with the FY2025 full-year figure at -$7178.9, up 49.01% from the prior year.
- Interest Expenses was -$3647.5 for Q2 2026 at MindWalk Holdings, down from -$2810.9 in the prior quarter.
- Over five years, Interest Expenses peaked at $241810.9 in Q3 2022 and troughed at -$3.7 million in Q4 2023.
- A 5-year average of -$411122.2 and a median of -$3647.5 in 2026 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses tumbled 839.47% in 2022 and jumped 99.94% in 2024, its largest moves.
- Over 5 years, Interest Expenses stood at -$1.5 million in 2022, then tumbled by 144.89% to -$3.7 million in 2023, then jumped by 99.94% to -$2196.9 in 2024, then declined by 27.95% to -$2810.9 in 2025, then dropped by 29.76% to -$3647.5 in 2026.
- The last three Interest Expenses figures came in at -$3647.5 (Q2 2026), -$2810.9 (Q2 2025), and -$2113.3 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 197.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | - |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 30.34 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | -48.79 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | -3,647.53 |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | 4,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -3,647.53 |
| Apr 30, 2025 | -2,810.91 |
| Jan 31, 2025 | -2,113.28 |
| Oct 31, 2024 | -2,196.87 |
| Apr 30, 2024 | -2,950.08 |
| Jan 31, 2024 | -3,698.61 |
| Oct 31, 2023 | -3.69 Mn |
| Jul 31, 2023 | -3,746.02 |
| Apr 30, 2023 | -19,954.33 |
| Oct 31, 2022 | -1.51 Mn |
| Jul 31, 2022 | 241,810.94 |
| Apr 30, 2022 | -532,160.16 |
| Jan 31, 2022 | 180,138.61 |
| Oct 31, 2021 | 203,632.07 |
| Jul 31, 2021 | 132,679.23 |
| Apr 30, 2021 | 147,891.85 |
| Jan 31, 2021 | 167,821.63 |
| Oct 31, 2020 | 128,429.27 |
| Apr 30, 2020 | 3,540.01 |
| Jan 31, 2020 | 105,934.24 |